Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils

Journal of Pharmacological Sciences

Volumn 110, Issue 3, 2009, Pages 276-284

  Beck Speier, Ingrid ^a   Oswald, Barbara ^a   Maier, Konrad L ^a   Karg, Erwin ^a   Ramseger, René ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Merck Selbstmedikation GmbH   (Germany)

Author keywords

Eicosanoid; Lipoxin A4; Neutrophil; Oxymetazoline; Rhinitis

Indexed keywords

15 HYDROXY EICOSATETRANOIC ACID; CARBON; ICOSATETRAENOIC ACID; OXYMETAZOLINE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; RESPIRATORY BURST;

EID: 67749120534     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09012FP     Document Type: Article

References (44)

1. Pitkaranta A, Viroleinen A, Jero J. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102:291-295. (Pubitemid 28354991)
2. Gwaltney JM Jr, Philips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25-30.
3. Kling S, Donninger H, Williams Z, Vermeulen J, Weinberg E, Latiff K, et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy. 2005;35:672-678. (Pubitemid 40769294)
4. Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114:239-247. (Pubitemid 39119019)
5. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982-986. (Pubitemid 23306765)
6. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002;19:68-75. (Pubitemid 34105570)
7. Grissell TV, Powell H, Shafren DR, Michael JB, Michael JH, Peter DJ, et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005;172:433-439. (Pubitemid 41117388)
8. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med. 1998;158:2453-2459. (Pubitemid 28555504)
9. Johnston NW, Johnston SL, Norman GR, Dai J, Sears MR. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol. 2006;117:557-562. (Pubitemid 43340218)
10. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58:37-42. (Pubitemid 36135356)
11. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med. 2003;115:272-277. (Pubitemid 37088188)
12. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168:968-975. (Pubitemid 37267175)
13. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114-1121. (Pubitemid 43726892)
14. Reinecke S, Tschaikin M. Investigation of the effect of oxymetazoline on the duration of rhinitis. Results of a placebo-controlled double-blind study in patients with acute rhinitis. MMW Fortschr Med. 2005;147:113-118.
15. Rakes GP, Arruda E, Ingram JM. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analysis. Am J Respir Crit Care Med. 1999;159:785-790. (Pubitemid 29137774)
16. Beck-Speier I, Dayal N, Karg, E, Maier KL, Schumann G, Semmler M, et al. Oxymetazoline inhibits proinflammatory reactions: Effect on arachidonic acid-derived metabolites. J Pharmacol Exp Ther. 2006;316:843-851. (Pubitemid 43131014)
17. Westerveld GJ, Scheeren RA, Dekker I, Griffioen DH, Voss HP, Bast A. Anti-oxidant actions of oxymetazoline and xylometazoline. Eur J Pharmacol. 1995;291:27-31.
18. Tuettenberg A, Koelsch S, Knop J, Jonuleit H. Oxymetazoline modulates pro- inflammatory cytokines and the T cell stimulatory capacity of dendritic cells. Exp Dermatol. 2007;16:171-178. (Pubitemid 46242958)
19. Serhan CN. Resolution phase of inflammation: Novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101-137.
20. Van Cauwenberge PB, van Kempern MJP, Bechert C. The common cold. Acta Otorhinolaryngol Belg. 2000;54:397-401.
21. Winther B, Gwaltney JM, Mygind N, Hendlay JO. Viral-induced rhinitis. Am J Rhinol. 1998;12:17-20.
22. Roth C, Ferron GA, Karg E, Lentner B, Schumann G, Takenaka S, et al. Generation of ultrafine particles by spark discharging. Aerosol Sci Technol. 2004;38:228-235. (Pubitemid 38174687)
23. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med. 2005;38:1080-1092. (Pubitemid 40386554)
24. Allen RC. Phagocytoc leukocyte oxygenation activities and chemiluminescence: a kinetic approach in analysis. Methods Enzymol. 1986;133:449-493.
25. Beck-Speier I, Leuschel L, Luippold LG, Maier KL. Proteins released from stimulated neutrophils contain very high levels of oxidized methionine. FEBS Lett. 1988;227:1-4. (Pubitemid 18021846)
26. 2: effect of antiinflammatory drugs on cyclooxygnease activity and prostanoid expression. Anal Biochem. 1999;271:18-28.
27. Mishra A, Dayal N, Beck-Speier I. Effect of sulphite on the oxidative metabolism of human neutrophils: studies with lucigenin- and luminal-dependent chemiluminescence. J Biolumin Chemilumin. 1995;10:9-19.
28. Merck Selbstmedikation GmbH. Nasivin® without preservatives for adults and schoolchildren. Physician information Status. March, 2008.
29. Horie K, Obika K, Foglar R, Tsuimoto G. Selectivity of the imidazoline α-adrenoceptors agonists (oxymetazoline and cirazoline) for human cloned α1-adrenoceptor subtypes. Br J Pharmacol. 1995:116:1611-1618.
30. Obika K, Shibata K, Horie K, Foglar R, Kimura K, Tsujimoto G. NS-49, a novel α1a-adrenoceptor-selective agonist characterization using recombinant human α1-adrenoceptors. Eur J Pharmacol. 1995:291:327-334. (Pubitemid 3014601)
31. 2+ elevation in Chinese hamster ovary cells. J Pharmacol Exp Ther. 1998:287:667-671.
32. Pauwels PJ, Finana F, Tardif S, Colpaert FC, Wurch T. Agonist efficacy at the α2A-adrenoceptor:Gα15 fusion protein: an analysis based on Ca2+ responses. Naunyn Schmiedebergs Arch Pharmacol. 2000:361:672-679. (Pubitemid 30350845)
33. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med. 2002;112 Suppl 6A:13S-18S.
34. Gentile DA, Skoner DP. Viral rhinitis. Curr Allergy Asthma Rep. 2001;1:227-234.
35. Denzlinger C. Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol. 1996;23:167-228.
36. Vancheri C, Mastruzzo D, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 2004;25:40-46. (Pubitemid 38032806)
37. Flamand N, Surette ME, Picard S, Bourgoin S, Borgeat P. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene synthesis in human neutrophils. Mol Pharmacol. 2002;62:250-256. (Pubitemid 34804103)
38. Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, Kuehl FA Jr. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci U S A. 1983;80:4349-4353.
39. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol. 2001;2:612-619. (Pubitemid 32677628)
40. Profita M, Sala A, Riccobono L, Pace E, Paterno A, Zarini S, et al. 15(S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis. Am J Physiol Cell Physiol. 2000;279:C1249-C1258. (Pubitemid 30951390)
41. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J. Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis- 13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 1993;92:1572-1579.
42. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous antiinflammatory lipid mediators. J Immunol. 2003;171:6856-6865. (Pubitemid 37532121)
43. Kim KS, Chun HS, Yoon JH, Lee JG, Lee JH, Yoo JB. Expression of 15-lipoxygenase-1 in human nasal epithelium: Its implication in mucociliary differentiation. Prostaglandins Leukot Essent Fatty Acids. 2005;73:77-83.
44. Han HY, Nabe T, Mizutani N, Fujii M, Terada T, Takenaka H, et al. Nasal blockade induced by oral administration of nonsteroidal anti-inflammatory drugs in a guinea-pig model of allergic rhinitis. J Pharmacol Sci. 2007;105:251-257. (Pubitemid 350145944)